Elekta AB

Elekta AB

Swedish medical technology company founded in 1972, producing radiation therapy and radiosurgery systems including the Leksell Gamma Knife for cancer treatment.

Visit Website

Company Overview

Elekta AB is a Swedish medical technology company headquartered in Stockholm, Sweden, founded in 1972 by Lars Leksell and Laurent Leksell to commercialize the Leksell Stereotactic System and the Gamma Knife — a device that delivers focused beams of radiation to treat tumors and brain disorders without conventional surgery. Elekta designs and manufactures radiation therapy systems, radiosurgery devices, and clinical management software for the treatment of cancer and neurological conditions. The company's product portfolio includes the Leksell Gamma Knife, linear accelerators, brachytherapy systems, and oncology software platforms.

More than 2 million patients are treated annually using Elekta solutions across 130 countries. Elekta employs over 4,000 staff in more than 40 countries and is listed on Nasdaq Stockholm under the ticker EKTAb. Corporate headquarters: Hagaplan 4, Stockholm, Sweden.

Capabilities & Activities

Primary type & automation activities this supplier delivers:

Applications & Industries

Product Categories

Products & Solutions

Leksell Gamma Knife

Stereotactic radiosurgery system delivering focused radiation beams to treat brain tumors and neurological disorders without open surgery.

Partnership & Notable clients

Associating Events

Listed in RobotToday Supplier Discovery. Verified Profile

More related news

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
    RobotToday Weekly October 12 – 16, 2026 RobotToday  · Oct 17, 2026
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

Contact Elekta AB

WEBSITE

https://www.elekta.com

PHONE

+46 8 587 254 00

HEADQUARTERS

Hagaplan 4
Stockholm , Stockholm County  113 47

Sweden

Company Facts

Founded

1972

Primary Role

Manufacturer

Company Size

-

Primary Region

Europe

Annual Sales

-

Funding Stage

-

Funding Total

-